Enduring Material

Psound Bytes: Systemic Non-Biologic Therapies
View Activity Info
Enter Basic User Info
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
 
 
National Psoriasis Foundation

6600 SW 92nd Ave., Suite 300
Portland, OR 97223-7195
General Information
Wednesday, July 15, 2020 - Thursday, July 15, 2021
National Psoriasis Foundation
Virtual Conference Room
Psound Bytes: AAD/NPF Psoriasis Treatment Guidelines
National Psoriasis Foundation
Objectives
  • Understand the AAD-NPF updated psoriasis guidelines and the recommendations for each therapy and class presented based on evidence and special considerations
  • Recognize the role of the provider in patient education and comprehensive care including shared-decision making based on patient preference, therapy considerations, patient circumstances and related comorbid conditions and health risks
  • Guide patients on recommendations for screening to address the risk of comorbidities
Presentations and Speakers
Psound Bytes: Systemic Non-Biologic Therapies
  • Ken Gordon, MD
Available Credits/Points
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.5 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Discover why it's important to have guidelines addressing the use of systemic nonbiologic therapies and why oral agents still play a role now and in the future treatment of psoriatic disease from one of the country's leading prescribers, dermatologist Dr. Kenneth Gordon, Professor and Chair of Dermatology at Froedtert and Medical College of Wisconsin in Milwaukee.
Disclosure Statements
Andi Agnew, NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.
Speakers:
Kenneth Gordon, MD has disclosed a relevant financial relationship with a commercial interest in the last 12 months:
  • Abbvie, BMS, Celgene, Janssen, Lilly, Novartis, UCB - Contracted Research
  • Abbvie, Almirall, Amgen, BMS, Celgene, Dermavant, Dermira, Janssen, Kyowa Hakko Kirin, Leo, Lilly, Novartis, Pfizer, Ortho, Sun, UCB - Consulting
This activity is supported by educational grants from Celgene and Ortho Dermatologics.
Accreditation Statement
  • The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
100 %
7/15/2020
Continue to Enduring Material